drugset
drugset / Trial / NCT03585725

A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma

NCT03585725 ↗

Phase 0 Terminated 3 enrolled Weill Medical College of Cornell University Memorial Sloan Kettering Cancer Center · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma

Timeline

Start
2018-09-26
Primary completion
2020-07-22
Completion
2020-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Ribavirin Small molecule 1000 mg Oral

Indications

follicular lymphoma mantle cell lymphoma